Cleave-stage Transfer on Day 3 Versus Day 5 Transfer When Only One Embryo Available

Infertility Clinical Trial

— Cleave-blast  

Official title:

Transfer of Single Embryo on Day 3 or 5 When Only One Embryo Transfer

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT04210414
• Other study ID #: IbnSina-ET
• Status: Terminated
• Phase: N/A
• Start date: January 10, 2020
• Est. completion date: November 10, 2021

Study information

• Verified date: June 2022
• Source: Ibn Sina Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

When only one embryo is available after in vitro fertilization, the option is to transfer either day 3 or day 5. There is no randomized trial compared the day 3 to day 5 for this subgroup.

Description:

Recruitment is very slow. The TSC will discuss termination next meeting with the DMC.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 83
• Est. completion date: November 10, 2021
• Est. primary completion date: November 10, 2021
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 42 Years

Eligibility

Inclusion Criteria:

• Infertile couple with only one embryo available for transfer

Exclusion Criteria:

• ineligible for study

Related Conditions & MeSH terms

• Infertility

Intervention

Other:
• Embryo transfer
Transfer of only one embryo

Locations

Country	Name	City	State
Egypt	Banon Assiut	Assiut
Egypt	Qena Fertility Center	Qena
Egypt	IbnSina IVF Center, IbnSina Hospital	Sohag

Sponsors (1)

Lead Sponsor	Collaborator
Ibn Sina Hospital

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Ongoing pregnancy rate		within 20 weeks of gestation
Secondary	Biochemical pregnancy rate		One month
Secondary	clinical pregnancy		7 weeks of gestation
Secondary	Embryo development after In vitro fertilization cycle		6 days after in vitro fertilization